# Internal Claude Code Review (Round 1)

**Role:** Internal review (Claude Code self-review)
**Paper:** Does Coverage Create Capacity? Medicaid Postpartum Extensions and the Supply of Maternal Health Providers
**Timestamp:** 2026-02-18T16:30:00
**Review mode:** Internal (Reviewer 2 + Editor)

---

## 1. FORMAT CHECK

- **Length**: Approximately 27-28 pages main text (before references/appendix). Meets 25+ requirement.
- **References**: 40+ references covering DiD methodology (CS, Goodman-Bacon, Sun & Abraham, de Chaisemartin, Borusyak et al., Rambachan & Roth), health economics (Clemens & Gottlieb, Decker, Polsky), and the postpartum coverage literature (Daw, Gordon, McMorrow). Adequate.
- **Prose**: All major sections in paragraph form. Bullets only in Data section for HCPCS code definitions and appendix variable definitions.
- **Section depth**: Each major section has 3+ paragraphs. Results section has 8 subsections.
- **Figures**: 8 figures with proper axes, confidence intervals, and descriptive notes.
- **Tables**: 4 tables with real data, standard errors, p-values, and sample sizes.

## 2. STATISTICAL METHODOLOGY

- **Standard Errors**: PASS. All coefficients have SEs in parentheses. Bootstrap scheme specified (state-level block bootstrap, 1,000 iterations).
- **Significance Testing**: PASS. p-values and star notation used. Joint pre-trend chi-squared test reported.
- **Confidence Intervals**: PASS. 95% CIs in event-study figures. HonestDiD sensitivity CIs reported.
- **Sample Sizes**: PASS. N = 4,284 state-months, 51 states reported consistently.
- **DiD with Staggered Adoption**: PASS. Uses Callaway & Sant'Anna (2021) doubly robust estimator with not-yet-treated controls. TWFE presented as robustness only, with appropriate caveats about attenuation bias.
- **RI permutations**: Updated to 1,000 (from 200). RI p-value = 0.198.

## 3. IDENTIFICATION STRATEGY

- **Credibility**: The design exploits clean state × time variation with 47 treated and 4 never-treated units. The CS-DiD estimator is appropriate.
- **Parallel trends**: Tested via event studies; joint pre-trend test fails to reject (χ² = 22.7, p = 0.54).
- **Placebos**: Antepartum (p = 0.806) and delivery (p = 0.863) placebos are null, as expected.
- **Key concern**: The balanced-panel result (ATT ≈ 0) is now prominently discussed in a dedicated subsection (Section 6.7), with the RI vs. conventional p-value discrepancy explained. The paper frames the full-sample estimate as an upper bound and the balanced-panel as a lower bound. This is honest and appropriate.
- **Limitations**: Thoroughly discussed, with data quality elevated from a minor caveat to a core identification challenge.

## 4. LITERATURE

Adequate. Now includes Sun & Abraham (2021), de Chaisemartin & D'Haultfoeuille (2020), Borusyak, Jaravel & Spiess (2024), and Sommers et al. (2016) in addition to the core references.

## 5. WRITING QUALITY

- **Prose**: Excellent. The opening hook ("190,000 women lost coverage") is compelling. The "unfunded mandate" framing is effective. Active voice throughout.
- **Narrative**: Clear arc from coverage cliff → provider supply question → data innovation → results → bounded interpretation.
- **Accessibility**: T-MSIS, PHE, and SPA explained clearly. Magnitudes contextualized (0.03 additional claims per Medicaid birth).
- **Tables**: Self-explanatory with comprehensive notes.
- **Conclusion**: Appropriately cautious, acknowledging bounded estimates while emphasizing the consistently positive direction.

## 6. CONSTRUCTIVE SUGGESTIONS

1. The code bundling discussion is well-placed in the Data section but could benefit from a brief mention in the Discussion when interpreting magnitudes.
2. The heterogeneity analysis (Section 6.8) is underpowered and adds little. Consider whether it earns its place in the main text.
3. Future work could exploit the post-PHE clean window more aggressively with CS-DiD restricted to that period.

## 7. OVERALL ASSESSMENT

**Key strengths:**
- Novel dataset (T-MSIS) applied to an understudied supply-side question
- State-of-the-art methodology (CS-DiD, HonestDiD, RI, DDD)
- Transparent and honest engagement with the balanced-panel limitation
- Excellent writing quality

**Critical weaknesses (addressed in this revision):**
- Data validity concern now prominently discussed with dedicated subsection
- RI vs. conventional p-value discrepancy now explained
- Claims appropriately softened to bounded interpretation

**Remaining limitations:**
- Cannot fully separate policy effects from T-MSIS reporting artifacts
- Few never-treated states limits power
- Provider "supply" is operationalized as billing participation for specific codes

DECISION: MINOR REVISION
